Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma, Ovarian Epithelial × Brachytherapy × Clear all

Sponsor

Conditions

Uterine Cervical Neoplasms 13 Prostatic Neoplasms 12 Neoplasms 4 Breast Neoplasms 3 Vaginal Neoplasms 2 Uterine Neoplasms 2 Esophageal Neoplasms 2 Endometrial Neoplasms 2 Endometrial Clear Cell Adenocarcinoma 2 Vulvar Neoplasms 1 Stage IA Uterine Sarcoma 1 Radiation Injuries 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Obesity 1 Neurotoxicity Syndromes 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Locally Advanced Cervical Cancer 1 Liver Neoplasms 1 Fatigue 1 Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation 1 Endometrial Adenocarcinoma 1 Desmoplastic Small Round Cell Tumor 1 Cholangiocarcinoma 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Carcinoma In Situ 1 Biliary Tract Neoplasms 1

Interventions

Paclitaxel 21 Carboplatin 16 liposomal doxorubicin 12 Bevacizumab 8 Topotecan 7 Docetaxel 7 Cisplatin 7 pembrolizumab 6 rucaparib 5 mirvetuximab soravtansine 5 Gemcitabine 5 Cyclophosphamide 5 Taxes 4 Albumin-Bound Paclitaxel 4 sargramostim 3 ixabepilone 3 Cytoreduction Surgical Procedures 3 130-nm albumin-bound paclitaxel 3 taxane 2 talazoparib 2 pazopanib 2 fludarabine phosphate 2 fludarabine 2 denileukin diftitox 2 cediranib 2 catumaxomab 2 belinostat 2 avelumab 2 aflibercept 2 Surgical Procedures, Operative 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡